Literature DB >> 7236071

Vidarabine therapy for herpes simplex encephalitis. The development of an unusual tremor during treatment.

A M Nadel.   

Abstract

A 33-year-old woman had an excellent response to vidarabine therapy after contracting herpes encephalitis. A dramatic tremor developed during the course of therapy but resolved after the drug was stopped.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7236071     DOI： 10.1001/archneur.1981.00510060086019

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


  3 in total

1.  Neurotoxic effects during vidarabine therapy for herpes zoster.

Authors:  D R Burdge; A W Chow; S L Sacks
Journal:  Can Med Assoc J       Date:  1985-02-15       Impact factor: 8.262

2.  Vidarabine encephalopathy.

Authors:  P A Cullis; R Cushing
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-12       Impact factor: 10.154

3.  Vidarabine-associated encephalopathy and myoclonus.

Authors:  R W Vilter
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.